CalciMedica, Inc. — Director's Dealing 2020

Sep 24, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: GRAYBUG VISION, INC. (GRAY)
CIK: 0001534133
Period of Report: 2020-09-24

Reporting Person: Cagle Gerald D. (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Preferred Stock	$		Common Stock (3322)		Direct
Director Stock Option (Right to Buy)	$2.26	2029-01-31	Common Stock (24769)		Direct
Director Stock Option (Right to Buy)	$1.00	2025-04-02	Common Stock (12012)		Direct
Director Stock Option (Right to Buy)	$1.00	2025-05-17	Common Stock (10613)		Direct
Director Stock Option (Right to Buy)	$1.63	2026-08-24	Common Stock (1100)		Direct
Director Stock Option (Right to Buy)	$2.26	2028-10-14	Common Stock (33311)		Direct
Director Stock Option (Right to Buy)	$16.00	2030-09-10	Common Stock (25000)		Direct

Footnotes

F1: Each share of the Issuer's Series B Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration and has no expiration date.

F2: The stock options are fully vested.